IVF Devices and Consumables Market Share & Size | By Top Leading Companies and Manufacturers With Industry Forecast [2018-2025]

Increase in adoption of IVF procedures across the world plays a major role in the growth of the IVF devices and consumables market. Furthermore, increase in number of infertile population with rise in success rate of IVF are expected to boost the demand for IVF devices and consumables in the coming years.

IVF Devices and Consumables Market Overview:
The global IVF devices and consumables market generated $1,882 million in 2017, and is projected to reach $6,891 million by 2025, growing at a CAGR of 17.6% from 2018 to 2025.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/864

In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in awareness toward IVF, growth in demand for advanced IVF technologies, and surge in IVF success rate are the key factors that drive the growth of the IVF devices and consumables market globally. However, the market growth is restricted by the higher costs associated with IVF devices, ethical issues, and complications associated with IVF.

Based on product, the accessory & disposable segment is the major revenue contributor, and is expected to dominate the market during the forecast period, due to their cost-effectiveness. However, the instrument segment is anticipated to grow at the highest rate, due to technological advancements and surge in demand for advanced IVF devices.

Based on technology, fresh embryo IVF is the major revenue contributor, and is estimated to show dominance during the forecast period, due to its advantages such as higher success rate, convenience, cost-effectiveness, and safety.

Depending on end user, the global IVF devices and consumables market is dominated by the fertility clinic segment, and is estimated to continue this trend during the forecast period, due to low cost of treatment and increase in number of fertility clinics. However, the surgical center segment is expected to grow at a significant rate, due to increase in number of surgery centers in the developing region and rise in use of IVF among the surgery centers.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/864

The key players profiled in this report include

Cook Medical Inc.,
FUJIFILM Holdings Corporation (Irvine Scientific Sales Company, Inc.),
Genea Biomedx,
Merck KGaA (EMD Serono, Inc.),
Ovascience Inc.,
Oxford Gene Technology,
Progyny Inc.,
The Cooper Companies,
Inc. (CooperSurgical, Inc.),
Thermo Fisher Scientific, Inc., and Vitrolife AB.

Key Benefits

- The study provides an in-depth analysis of the global IVF devices and consumables industry along with the current trends and future estimations to elucidate the imminent investment pockets.

- It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

- A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.

- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/864

Table Of Content

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Alternative technologies

3.2.1. Intrauterine insemination (IUI) technique

3.2.1.1. Benefits of IUI
3.2.1.2. Difference between IUI and IVF techniques

3.2.2. Gamete intra-fallopian transfer (GIFT) technique

3.2.2.1. Differences between GIFT and IVF technique

3.2.3. Zygote intrafallopian transfer (ZIFT) technique

3.2.3.1. Differences between ZIFT and IVF technique

3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES

3.3.1. Female infertility treatments
3.3.2. Risks associated with fertility drugs
3.3.3. Male infertility treatment

3.4. COST OF IVF PROCEDURES
3.5. ROLE OF DONORS IN THE IVF MARKET

3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research

3.6. Surrogacy

3.6.1. Legal issues

3.7. IVF TRENDS IN SAME SEX COUPLES

3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In vitro fertilization

3.8. ADVANCED IVF TECHNOLOGIES

3.8.1. Capsule IVF
3.8.2. Three parent IVF

3.8.2.1. Ethical concerns

3.8.3. Mini IVF

3.8.3.1. Advantages
3.8.3.2. Drawbacks

3.8.4. Embryo scope

3.8.4.1. Advantages
3.8.4.2. PICSI

3.9. FERTILITY TREATMENT AND GENDER SELECTION

3.9.1. Methods of sex selection

3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)

3.9.1.3.1. Ethical and legal issues

3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
3.11. APPLICATION OF STEM CELLS IN IVF
3.12. IVF AND RESOURCE-POOR COUNTRIES
3.13. KEY FINDINGS

3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies

3.14. PORTER’S FIVE FORCES ANALYSIS

3.14.1. High competition and large number reduces the power of suppliers
3.14.2. Scattered nature and large count of end users moderate the buyer power
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes

3.15. VALUE CHAIN ANALYSIS
3.16. PATENT ANALYSIS

3.16.1. Patent analysis, by year
3.16.2. Patents analysis, by country

3.17. REGULATORY ISSUES AND LEGISLATIONS
3.18. INSURANCE REIMBURSEMENT SCENARIO
3.19. CLINICAL TRIAL
3.20. Drivers

3.20.1. Delayed pregnancies in women
3.20.2. Increase in global infertility rates
3.20.3. Technological advancement in IVF devices
3.20.4. Increase in gamete donations
3.20.5. Increase in disposable income
3.20.6. Increase in success rates
3.20.7. Surge in healthcare expenditure worldwide

3.21. Restraints

3.21.1. Cost constraints
3.21.2. Complications associated with IVF treatment
3.21.3. Low awareness level

3.22. Opportunities

3.22.1. Fertility tourism
3.22.2. Growth opportunities in the emerging markets
3.22.3. Increase in number of fertility clinics
3.22.4. Rise in same sex marriage

3.23. Impact analyses

Access Full Summery @ https://www.alliedmarketresearch.com/in-vitro-fertilization-devices-and-consumables-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.